Kishioka S, Nishida S, Fukunaga Y, Yamamoto H
Department of Pharmacology, Wakayama Medical College, Japan.
Jpn J Pharmacol. 1994 Oct;66(2):257-63. doi: 10.1254/jjp.66.257.
Elevation of plasma corticosterone (PCS) has been used as an indicator of morphine withdrawal, but it is not clear whether the magnitude of elevation is related to the intensity of the dependence. The dose-dependent effects of naloxone on PCS and body weight were studied in male Sprague-Dawley rats rendered physically dependent on morphine by injecting increasing doses of 40-120 mg/kg/day, s.c. twice daily for 1-6 days. Naloxone (0.01-2.0 mg/kg, s.c.) was administered 3 hr after the last morphine administration. Naloxone elevated PCS levels in a dose-dependent manner in all groups treated with morphine, and the elevation was correlated with the number of days of morphine treatment. Naloxone also reduced dose-dependently the body weight in all groups treated with morphine; in this case, a reverse correlation was obtained between the body weight changes and the PCS levels. It was confirmed that PCS elevation is a quantitative sign of naloxone-precipitated morphine withdrawal and that the elevation is indicative of the degree of morphine physical dependence.
血浆皮质酮(PCS)升高已被用作吗啡戒断的指标,但升高幅度是否与依赖强度相关尚不清楚。通过每天皮下注射递增剂量的40 - 120 mg/kg,分两次注射,持续1 - 6天,使雄性Sprague-Dawley大鼠对吗啡产生身体依赖,研究了纳洛酮对PCS和体重的剂量依赖性影响。在最后一次注射吗啡3小时后给予纳洛酮(0.01 - 2.0 mg/kg,皮下注射)。纳洛酮在所有接受吗啡治疗的组中均以剂量依赖性方式升高PCS水平,且升高与吗啡治疗天数相关。纳洛酮还在所有接受吗啡治疗的组中剂量依赖性地降低体重;在这种情况下,体重变化与PCS水平呈负相关。证实了PCS升高是纳洛酮诱发的吗啡戒断的定量标志,且该升高表明吗啡身体依赖的程度。